Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
BACKGROUND:Epidemiological studies suggest that metformin may reduce the incidence of cancer in patients with diabetes and multiple late phase clinical trials assessing the potential of repurposing this drug are underway. Transcriptomic profiling of tumour samples is an excellent tool to understand...
Main Authors: | Lord, S, Collins, J, Cheng, W, Haider, S, Wigfield, S, Gaude, E, Fielding, B, Pinnick, K, Harjes, U, Segaran, A, Jha, P, Hoefler, G, Pollak, M, Thompson, A, Roy, P, English, R, Adams, R, Frezza, C, Buffa, F, Karpe, F, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Research
2019
|
Similar Items
-
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
by: Lord, SR, et al.
Published: (2011) -
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
by: Lord, SR, et al.
Published: (2011) -
Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer
by: Lord, S, et al.
Published: (2018) -
Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer
by: Lord, S, et al.
Published: (2018) -
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.
by: Bensaad, K, et al.
Published: (2014)